Organovo Holdings Inc (ONVO)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Keith Murphy
Employees:
9
6275 NANCY RIDGE DRIVE, SUITE 110, SAN DIEGO, CA 92121
858-550-9994

Organovo Holdings, Inc. focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells. The company is developing in vivo liver tissues to treat end-stage liver, life-threatening, and orphan diseases.

Data derived from most recent annual or quarterly report
Market Cap 28.528 Million Shares Outstanding8.711 Million Avg 30-day Volume 44.473 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.3
Price to Revenue0.0 Debt to Equity0.0 EBITDA-16.798 Million
Price to Book Value1.6975 Operating Margin0.0 Enterprise Value29.171 Million
Current Ratio53.257 EPS Growth0.129 Quick Ratio51.823
1 Yr BETA 1.3638 52-week High/Low 8.3 / 1.71 Profit Margin0.0
Operating Cash Flow Growth10.4757 Altman Z-Score44.718 Free Cash Flow to Firm -14.335 Million
View SEC Filings from ONVO instead.

View recent insider trading info

Funds Holding ONVO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ONVO

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-03-10:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-02-28:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-11-19:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-10-06:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-10-01:
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-09-17:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-05-13:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2021-04-19:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2021-03-10:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-12-31:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    GOBEL DAVID

    • Director
    0 2022-03-31 2

    JOSHI VAIDEHI

    • Director
    0 2022-03-08 2

    JURGENSEN THOMAS E GENERAL COUNSEL & SECRETARY

    • Officer
    52,023 2021-10-07 1

    STERN ADAM K

    • Director
    17,500 2021-10-07 1

    MURPHY KEITH EXECUTIVE CHAIRMAN

    • Officer
    • Director
    137,500 2021-10-07 1

    COHEN DOUGLAS JAY

    • Director
    17,500 2021-10-07 2

    MINER JEFFREY N. CHIEF SCIENTIFIC OFFICER

    • Officer
    77,023 2021-10-07 1

    MILHOUS ALISON TJOSVOLD

    • Director
    17,500 2021-10-07 1

    HESS THOMAS PRESIDENT, CFO AND PFO

    • Officer
    0 2021-10-06 1

    HEBERLIG CHRIS PRESIDENT AND CFO

    • Officer
    0 2020-09-15 0

    KUSSMAN CRAIG CHIEF FINANCIAL OFFICER

    • Officer
    221,743 2020-08-18 0

    CROUCH TAYLOR CEO & PRESIDENT

    • Officer
    • Director
    125,144 2020-08-18 0

    BUSH JENNIFER GENERAL COUNSEL & SECRETARY

    • Officer
    192,758 2020-08-18 0

    KESSEL MARK

    • Director
    0 2019-09-05 0

    MALLOY KIRK

    • Director
    0 2019-09-05 0

    BEAVER CAROLYN

    • Director
    0 2019-09-05 0

    MAROUN RICHARD E

    • Director
    0 2019-09-05 0

    SHAPIRO DAVID

    • Director
    0 2019-09-05 0

    GALLANT PAUL GENERAL MANAGER

    • Officer
    191,335 2019-08-16 0

    HUGHES STEVEN GEORGE CHIEF MEDICAL OFFICER

    • Officer
    138,484 2019-08-16 0

    PRESNELL SHARON COLLINS CHIEF SCIENTIFIC OFFICER

    • Officer
    280,993 2018-11-16 0

    HOWSON TAMAR D

    • Director
    0 2018-07-26 0

    GLOVER JAMES T

    • Director
    0 2018-07-26 0

    BALTERA ROBERT JR.

    • Director
    0 2018-07-26 0

    DAVID ERIC CSO & EVP PRE-CLINICAL DEV

    • Officer
    876,609 2017-11-16 0

    MICHAELS BARRY D CHIEF FINANCIAL OFFICER

    • Officer
    No longer subject to file 2016-03-31 0

    HEYMAN RICHARD A.

    • Director
    0 2015-08-20 0

    RENARD MICHAEL EVP OF COMMERCIAL OPERATIONS

    • Officer
    0 2015-06-04 0

    FORGACS ANDRAS

    • Director
    0 2012-10-18 0

    KIMBERLIN KEVIN

    • 10% Owner
    No longer subject to file 2012-09-27 0

    FORGACS GABOR CHIEF SCIENTIFIC OFFICER

    • Officer
    6,053,991 2012-03-13 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ORGANOVO HOLDINGS INC ONVO 2022-08-12 22:15:03 UTC -22.7379 25.0579 85000
    ORGANOVO HOLDINGS INC ONVO 2022-08-12 21:45:04 UTC -22.7379 25.0579 85000
    ORGANOVO HOLDINGS INC ONVO 2022-08-12 21:15:04 UTC -22.7379 25.0579 85000
    ORGANOVO HOLDINGS INC ONVO 2022-08-12 20:45:04 UTC -22.723 25.043 85000
    ORGANOVO HOLDINGS INC ONVO 2022-08-12 20:15:05 UTC -22.723 25.043 85000
    ORGANOVO HOLDINGS INC ONVO 2022-08-12 19:45:03 UTC -22.723 25.043 85000
    ORGANOVO HOLDINGS INC ONVO 2022-08-12 19:15:05 UTC -22.723 25.043 85000
    ORGANOVO HOLDINGS INC ONVO 2022-08-12 18:45:03 UTC -23.0331 25.3531 85000
    ORGANOVO HOLDINGS INC ONVO 2022-08-12 18:15:04 UTC -23.0331 25.3531 85000
    ORGANOVO HOLDINGS INC ONVO 2022-08-12 17:45:04 UTC -23.0331 25.3531 85000
    ORGANOVO HOLDINGS INC ONVO 2022-08-12 17:15:05 UTC -23.0331 25.3531 80000
    ORGANOVO HOLDINGS INC ONVO 2022-08-12 16:45:04 UTC -26.0133 28.3333 85000
    ORGANOVO HOLDINGS INC ONVO 2022-08-12 16:15:04 UTC -26.0133 28.3333 85000
    ORGANOVO HOLDINGS INC ONVO 2022-08-12 15:45:04 UTC -26.0133 28.3333 85000
    ORGANOVO HOLDINGS INC ONVO 2022-08-12 15:15:05 UTC -26.0133 28.3333 85000
    ORGANOVO HOLDINGS INC ONVO 2022-08-12 14:45:04 UTC -26.0133 28.3333 90000
    ORGANOVO HOLDINGS INC ONVO 2022-08-12 14:15:05 UTC -26.0133 28.3333 90000
    ORGANOVO HOLDINGS INC ONVO 2022-08-12 13:45:04 UTC -23.8952 26.2152 90000
    ORGANOVO HOLDINGS INC ONVO 2022-08-12 13:15:04 UTC -23.8952 26.2152 85000
    ORGANOVO HOLDINGS INC ONVO 2022-08-12 12:45:04 UTC -23.8952 26.2152 75000

    Current Active Short Positions

    Get more info on our International short position coverage here

    Holder Issuer Net Short Position Position Date Origin

    Short Position History (International Only)

    Holder Net Short Position Position Date Origin
    Squarepoint Ops LLC Organovo Holdings, Inc. 0.5% 2020-08-27 GERMANY

    Elevate your investments